CIPDB › China Industry › Chemicals › Pharmaceutical Intermediate
Factory Supply Cinnarizine CAS 298-57-7 Pharmaceutical Grade Cinnarizine Powder1
Pharmaceutical IntermediateCinnarizineFactory Supply Cinnarizine
Shaanxi Haibo Biological Technology Co., Ltd
Preview:
Product Description Cinnarizine is a medication derivative of characterized as an antihistamine and a calcium channel blocker, it is also known to promote cerebral blood flow, and so is used to treat cerebral apoplexy, post-trauma cerebral symptoms, and cerebral arteriosclerosis. However, it is more commonly prescribed for nausea and vomiting due to motion sickness or other sources such as chemotherapy, vertigo, or Ménière's disease. Cinnarizine was first synthesized by Janssen Pharmaceutica in 1955. The nonproprietary name is derived from the cinnamyl substituent on one of the nitrogen atoms, combined with the generic ending "-rizine" for "antihistaminics/cerebral (or peripheral) vasodilators". It is not available in the United States or Canada. It is manufactured and marketed in Bangladesh under the trade name Suzaraon by Rephco Pharmaceuticals Limited. It has also been cited as one of the most used drugs for seasickness within the British Royal Navy. ItemTest StandardTesting ResultAssay99%CompliesApperenceWhite Powder CompliesParticle Size100% pass 80 meshCompliesOderCharacteristicCompliesTasteCharacteristicCompliesLoss on Drying≤5.0%2.20%Residue on Ignition≤0.1%0.05%Residual ≤0.1%CompliesResidual Ethanol≤0.5%CompliesHeave Mentals≤10ppmCompliesNa≤0.1%<0.1%Pb≤3 ppmCompliesTotal Plate<1000CFU/gCompliesYeast & Mold<100 CFU /gCompliesE. ColiNegativeCompliesSalmonellaNegativeComplies
Purchasing Agent
Note: Send your message to supplier or manufacturer.
Welcome to our Professional and comprehensive procurement services...